Hiroki Ito, Kentaro Sakamaki, Grace J Young, Peter S Blair, Hashim Hashim, J Athene Lane, Kazuki Kobayashi, Madeleine Clout, Paul Abrams, Christopher Chapple, et al. Predicting Prostate Surgery Outcomes from Standard Clinical Assessments of Lower Urinary Tract Symptoms To Derive Prognostic Symptom and Flowmetry Criteria. European urology focus. 2024. 10. 1. 197-204
Musashi Fukuda, Kentaro Sakamaki, Koji Oba. The net benefit for time-to-event outcome in oncology clinical trials with treatment switching. Clinical trials (London, England). 2023. 20. 6. 670-680
Yutaka Kurebayashi, Hanako Tsujikawa, Katsutoshi Sugimoto, Daisuke Yunaiyama, Yoichi Araki, Kazuhiro Saito, Hiroshi Takahashi, Tatsuya Kakegawa, Takuya Wada, Yusuke Tomita, et al. Tumor Steatosis and Glutamine Synthetase Expression in Patients with Advanced HCC Receiving Atezolizumab plus Bevacizumab Therapy. Hepatology Research. 2023. 53. 10. 1008-1020
Kanako Fuyama, Mitsunori Ogawa, Junki Mizusawa, Yukihide Kanemitsu, Shin Fujita, Takuya Kawahara, Kentaro Sakamaki, Koji Oba. Impact of correlations between prioritized outcomes on the net benefit and its estimate by generalized pairwise comparisons. Statistics in medicine. 2023. 42. 10. 1606-1624
Tomoko Kurita, Kanae Taruno, Seigo Nakamura, Hiroyuki Takei, Katsutoshi Enokido, Takashi Kuwayama, Yoko Kanada, Sadako Akashi, Maki Nakai, Meishi Hankyo, et al. Magnetic guided localization for non-palpable breast lesion: A multi-center open-label trial in Japan. CANCER RESEARCH. 2020. 80. 4
Yuichiro Kikawa, Kentaro Sakamaki, Tomomi Fujisawa, Kazuhiro Araki, Takayuki Iwamoto, Takafumi Sangai, Tadahiko Shien, Shintaro Takao, Reiki Nishimura, Masato Takahashi, et al. HEALTH-RELATED QUALITY OF LIFE IN 2ND-LINE ENDOCRINE THERAPY FOR PATIENTS WITH ACQUIRED ENDOCRINE-RESISTANT POSTMENOPAUSAL ER-POSITIVE, HER2-NEGATIVE METASTATIC BREAST CANCER: THE HORSE-BC STUDY. BREAST. 2019. 48. S72-S73
Yutaka Yamamoto, Hiroji Iwata, Norikazu Masuda, Tomomi Fujisawa, Tatsuya Toyama, Masahiro Kashiwaba, Shoichiro Ohtani, Naruto Taira, Takehiko Sakai, Yoshie Hasegawa, et al. TransNEOS: Validation of the oncotype DX recurrence score (RS) testing core needle biopsy samples from NEOS as predictor of clinical response to neoadjuvant endocrine therapy for postmenopausal estrogen receptor positive (ER+), HER2 negative (HER2-) breast cancer patients. CANCER RESEARCH. 2018. 78. 4
